Market worries about a global growth slowdown have increased following virus resurgence, uncertainty about US fiscal stimulus, and China growth concerns. At the same time, the spending of "excess" savings households have accumulated during the pandemic once normal economic life returns could in principle sustain rapid growth. We estimate the growth boost from running down these “excess” savings in large economies.
Households have accumulated $5tn in excess savings globally, concentrated among advanced economies, led by the US and Canada with 12% of 2019 GDP, and the UK with 10%. Excess savings are generally smaller in the emerging world but do account for 5% of GDP in India. Not surprisingly, countries with the most fiscal support in 2020 also have the highest excess savings.
Both the form in which excess savings are held and their distribution across households suggest that the propensity to consume out of savings will be larger than the typical propensity to spend out of wealth. We estimate that liquid currency and deposits have increased by an amount corresponding to 90% of excess savings across DMs. Although most of the excess savings in the US, Japan, and Canada are held by top income earners, when viewed as a share of consumption, they are distributed more equally.
We estimate that 14% of excess savings will be spent within a year of reopening, on average, based on estimates from our US and Japan teams, the US and UK WW2 experience, and surveys. We estimate a peak boost from the run-down in excess savings, and inclusive of delayed effects of fiscal support to households, to the level of global GDP of 1% in mid-2022, and to global growth of 1¼pp at the start of next year. The GDP boost is the largest in the US and UK, peaking at 2¼%, followed by Canada, Japan, and Australia. The impact is more moderate in the Euro Area, and smaller in emerging markets, except for India.
Overall, our analysis of pent-up savings supports our still above consensus global GDP growth forecasts of 6.5% in 2021 and 4.8% in 2022, along with our optimistic view on global vaccinations.
Investors should consider this report as only a single factor in making their investment decision. For Reg AC certification and other important disclosures, see the Disclosure Appendix, or go to www.gs.com/research/hedge.html.